NYSE: LCTX
Lineage Cell Therapeutics insiders
The officers, directors and 10% owners of Lineage Cell Therapeutics, Inc. who hold the most stock, valued at the live LCTX price.
$0.82
LCTX today −$19K (−2.21%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their LCTX stock
- $128M
- Market value
- $207M
- Held by ranked insiders
- 61.7%
Insiders by value of LCTX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Broadwood Capital INC | 10% owner | 99,121,984 | $81.3M | 39.2% | Corporate |
| 2 | Broadwood Partners, L.P. | Director | 50,560,992 | $41.5M | 20.0% | Corporate |
| 3 | Alfred D. Kingsley | Director | 6,473,891 | $5.3M | 2.56% | 13802nd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Lineage Cell Therapeutics; see each profile for the filing.